Share the post "Mutual Fund Data: Stock Market today Insights for – 26 Aug 2024"
| Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|---|
 |
Medplus Health Services | Icici Prudential Pharma Healthcare & Diagnostics (phd) Fund | Buy | 1M | 616.00 | Lavender Rose Investment |
| Icici Prudential India Opportunities Fund | Buy | 1M | 616.00 | Lavender Rose Investment | ||
| Icici Prudential Innovation Fund | Buy | 604K | 616.00 | Lavender Rose Investment | ||
| Icici Prudential Multi-asset Fund | Buy | 966K | 616.00 | Lavender Rose Investment | ||
 |
Nitco | Jm Financial Asset Reconstruction Company | Sell | 510K | 90.83 | Na |
The 1M shares of Medplus Health Services have been purchased by the by Icici Prudential Pharma Healthcare & Diagnostics (phd) Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 1M shares of Medplus Health Services have been purchased by the by Icici Prudential India Opportunities Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 604K shares of Medplus Health Services have been purchased by the by Icici Prudential Innovation Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 966K shares of Medplus Health Services have been purchased by the by Icici Prudential Multi-asset Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 510K shares of Nitco have been sold by the by Jm Financial Asset Reconstruction Company through mutual funds at a price of ₹90.83 per share.
Medplus Health Services Limited
14,888.25
Net Sales
143.44
Net Profit
14,975.37
Total Income
14,797.50
Expenditure
668
Current Price
7,981
Market Cap
In Medplus Health Services Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹14,888.25 million, with total income of ₹14,975.37 million. The expenditure was ₹14,797.50 million, leading to a net profit of ₹143.44 million. Earnings per Share (EPS) for continuing operations were reported at ₹1.20. The financial overview also includes other income of ₹87.12 million, finance costs of ₹246.58 million, and employee benefit expenses totaling ₹1,618.22 million. Depreciation and amortization expenses were ₹600.30 million. Current and deferred taxes were recorded at ₹60.44 million and ₹-26.01 million, respectively. The total comprehensive income for the period was ₹143.44 million, and other comprehensive income net of taxes was ₹0.00 million.
With a market capitalization of ₹7,981 crore, the company’s stock is currently priced at ₹668. The historical trading range of the stock is ₹849 / 598. The P/E ratio is remarkably high at 105, suggesting a significant valuation. The book value stands at ₹132, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 6.66%, and the Return on Equity (ROE) is 4.10%. The debt-to-equity ratio is very low at 0.64, though the company shows a negative net cash flow of ₹-137 crore. The Piotroski score is 6.00, with the Graham Number pegged at ₹137. The Price-to-Book (P/B) ratio of 5.06 highlights a premium valuation.
Nitco Limited
702.22
Net Sales
-435.20
Net Profit
713.84
Total Income
1,149.04
Expenditure
83.6
Current Price
601
Market Cap
In Nitco Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹702.22 million, with total income of ₹713.84 million. The expenditure was ₹1,149.04 million, leading to a net profit of ₹-435.20 million. Earnings per Share (EPS) for continuing operations were reported at ₹-6.06. The financial overview also includes other income of ₹11.62 million, finance costs of ₹267.42 million, and employee benefit expenses totaling ₹127.95 million. Depreciation and amortization expenses were ₹71.46 million. Current and deferred taxes were recorded at ₹0.00 million and ₹0.00 million, respectively. The total comprehensive income for the period was ₹-435.62 million, and other comprehensive income net of taxes was ₹-0.42 million.
The company has a market capitalization of ₹601 crore and a current stock price of ₹83.6. Historically, the stock has fluctuated between ₹95.0 / 17.7. With a Price-to-Earnings (P/E) ratio of , the stock appears highly valued. The book value per share is ₹-71.3, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is -14.0% and the Return on Equity (ROE) is %. The debt-to-equity ratio is very low at , although the company reports a net cash flow of ₹-3.92 crore. The Piotroski score is 2.00, and the Graham Number estimates the intrinsic value of the stock at ₹. The Price-to-Book (P/B) ratio is , indicating the stock is trading at a premium relative to its book value.
